{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:48:52Z","timestamp":1794656932977,"version":"4.9.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019624","name":"University Hospital Hradec Kralove","doi-asserted-by":"publisher","award":["23-07570S"],"award-info":[{"award-number":["23-07570S"]}],"id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019624","name":"University Hospital Hradec Kralove","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/23_021\/0008439"],"award-info":[{"award-number":["CZ.02.01.01\/00\/23_021\/0008439"]}],"id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010609","name":"Medical University of Gdansk","doi-asserted-by":"publisher","award":["2022\/47\/D\/NZ7\/01043"],"award-info":[{"award-number":["2022\/47\/D\/NZ7\/01043"]}],"id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Czech Academy of Sciences","doi-asserted-by":"publisher","award":["RVO 61388963"],"award-info":[{"award-number":["RVO 61388963"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014911","name":"Ministerstvo Obrany \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032164","name":"Univerzita Obrany","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032164","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejmech.2025.117678","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T18:55:49Z","timestamp":1745348149000},"page":"117678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Novel tacrine-based multi-target directed Ligands: Enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatment"],"prefix":"10.1016","volume":"292","author":[{"given":"Barbora","family":"Svobodova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Moravcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Misiachna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Odvarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Pejchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana Zdarova","family":"Karasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Netolicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Ladislav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hrabinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Sorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubica","family":"Muckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Fikejzlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Benkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Capek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Handl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Rousar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna Ewa","family":"Greber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzesimir","family":"Ciura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117678_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.117678_bib2","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib3","unstructured":"Dementia, (n.d.). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia (accessed January 17, 2025)."},{"key":"10.1016\/j.ejmech.2025.117678_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.742408","article-title":"Alzheimer's disease: an update and insights into pathophysiology","volume":"14","author":"Abubakar","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2025.117678_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/biology12040602","article-title":"Potential molecular mechanisms of alzheimer's disease from genetic studies","volume":"12","author":"Nwadiugwu","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2025.117678_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2025.117678_bib7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2025.117678_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2008.06.005","article-title":"Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease","volume":"53","author":"P\u00e1k\u00e1ski","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2025.117678_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1567205043331992","article-title":"Alzheimer's disease: interactions between cholinergic functions and beta-amyloid","volume":"1","author":"Yan","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2025.117678_bib10","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.117678_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox9080647","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.117678_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117678_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer's disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1206572","article-title":"Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks","volume":"15","author":"Peng","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2025.117678_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","article-title":"Therapeutic approach to alzheimer's disease: current treatments and new perspectives","volume":"14","author":"Pardo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117678_bib16","author":"Fan"},{"key":"10.1016\/j.ejmech.2025.117678_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/ph14090930","article-title":"Antidepressants in alzheimer's disease: a focus on the role of mirtazapine","volume":"14","author":"Correia","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117678_bib19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/gps.4614","article-title":"Moderating risk of Alzheimer's disease through the use of anxiolytic agents","volume":"32","author":"Burke","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117678_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/d41586-023-00030-3","article-title":"FDA approves Alzheimer's drug lecanemab amid safety concerns","volume":"613","author":"Reardon","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117678_bib21","series-title":"FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117678_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117678_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117678_bib24","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0319-23.2024","article-title":"Lecanemab and donanemab as therapies for alzheimer's disease: an illustrated perspective on the data","volume":"11","author":"Espay","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.ejmech.2025.117678_bib25","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/med.21699","article-title":"From combinations to multitarget-directed ligands: a continuum in Alzheimer's disease polypharmacology","volume":"41","author":"Albertini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117678_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/d41586-023-00954-w","article-title":"Conquering Alzheimer's: a look at the therapies of the future","volume":"616","author":"Abbott","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117678_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.1992.tb04458.x","article-title":"Putative mechanisms of action of tacrine in Alzheimer's disease","volume":"139","author":"Adem","year":"1992","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.ejmech.2025.117678_bib29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1567205011310080011","article-title":"A resurrection of 7-MEOTA: a comparison with tacrine","volume":"10","author":"Soukup","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2025.117678_bib30","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.117678_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004836-199801000-00015","article-title":"Tacrine. A cause of fatal hepatotoxicity?","volume":"26","author":"Blackard","year":"1998","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ejmech.2025.117678_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib33","article-title":"Discovery of novel tacrine-pyrimidone hybrids as potent dual AChE\/GSK-3 inhibitors for the treatment of alzheimer's disease","volume":"64","author":"H","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/C9MD00396G","article-title":"Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds","volume":"11","author":"Lazzara","year":"2019","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41573-023-00703-8","article-title":"Deuterium in drug discovery: progress, opportunities and challenges","volume":"22","author":"Di Martino","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117678_bib36","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1016\/j.csbj.2021.07.041","article-title":"Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase \u2013 design, synthesis and biological evaluation","volume":"19","author":"Remya","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2025.117678_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113434","article-title":"Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors","volume":"219","author":"Gorecki","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116821","article-title":"Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists","volume":"176","author":"Chvojkova","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117678_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116130","article-title":"Phenoxytacrine derivatives: low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition","volume":"266","author":"Misiachna","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114460","article-title":"7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo","volume":"186","author":"Kaniakova","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117678_bib41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1021\/acschembio.3c00219","article-title":"Tacrine first-phase biotransformation and associated hepatotoxicity: a possible way to avoid quinone methide formation","volume":"18","author":"Novak","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117678_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115154","article-title":"UHPLC-orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes","volume":"224","author":"Novak","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2025.117678_bib43","doi-asserted-by":"crossref","first-page":"27293","DOI":"10.1002\/anie.202112454","article-title":"The formal cross-coupling of amines and carboxylic acids to form sp3 -sp3 carbon-carbon bonds","volume":"60","author":"Zhang","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117678_bib44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/03602532.2015.1086781","article-title":"Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes","volume":"47","author":"Bolleddula","year":"2015","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2025.117678_bib45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apsb.2018.04.003","article-title":"Drug metabolism in drug discovery and development","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117678_bib46","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/jm4007998","article-title":"Using deuterium in drug discovery: leaving the label in the drug","volume":"57","author":"Gant","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/jm8008663","article-title":"Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS\/MS validation","volume":"52","author":"Trunzer","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/dmd.111.042770","article-title":"Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs","volume":"40","author":"Sharma","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2025.117678_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105875","article-title":"Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property","volume":"126","author":"Liu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/antibiotics10101237","article-title":"Can immobilized artificial membrane chromatography support the characterization of antimicrobial peptide origin derivatives?","volume":"10","author":"Ciura","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2025.117678_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2024.106951","article-title":"Green synthesis of 1,3,5-triazine derivatives using a sonochemical protocol","volume":"108","author":"Ku\u0142aga","year":"2024","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.ejmech.2025.117678_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464549","article-title":"Modeling of small molecule's affinity to phospholipids using IAM-HPLC and QSRR approach enhanced by similarity-based machine algorithms","volume":"1714","author":"Ciura","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejmech.2025.117678_bib53","unstructured":"Exploring qsar : hydrophobic, electronic, and steric constants - hansch: 9780841229914 - AbeBooks, (n.d.). https:\/\/www.abebooks.co.uk\/9780841229914\/Exploring-Qsar-Hydrophobic-Electronic-Steric-0841229910\/plp (accessed February 14, 2025)."},{"key":"10.1016\/j.ejmech.2025.117678_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00194965","article-title":"Characteristics of plasma protein binding of tacrine hydrochloride: a new drug for Alzheimer's disease","volume":"47","author":"M\u00e4kel\u00e4","year":"1994","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117678_bib55","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2174\/1381612821666150302113710","article-title":"Studies on drug-human serum albumin binding: the current state of the matter","volume":"21","author":"Zhivkova","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.117678_bib56","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/ph15101220","article-title":"Design, synthesis and biological evaluation of biscarbamates as potential selective butyrylcholinesterase inhibitors for the treatment of alzheimer's disease","volume":"15","author":"Mato\u0161evi\u0107","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117678_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.ejmech.2025.117678_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117678_bib59","doi-asserted-by":"crossref","first-page":"16882","DOI":"10.3390\/ijms140816882","article-title":"Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study","volume":"14","author":"Sepsova","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib60","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.talanta.2009.12.052","article-title":"Colorimetric dipstick for assay of organophosphate pesticides and nerve agents represented by paraoxon, sarin and VX","volume":"81","author":"Pohanka","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2025.117678_bib61","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/jm201705f","article-title":"Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein","volume":"55","author":"Jabeen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib62","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic efficiency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4155\/fmc.12.208","article-title":"Lipophilic efficiency: the most important efficiency metric in medicinal chemistry","volume":"5","author":"Freeman-Cook","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib64","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.bmcl.2009.03.109","article-title":"Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower logD limits based on permeability","volume":"19","author":"Waring","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117678_bib65","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117678_bib66","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.bmcl.2009.05.062","article-title":"Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis","volume":"19","author":"Ryckmans","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117678_bib67","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113112","article-title":"2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease","volume":"211","author":"Mezeiova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib69","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.21580","article-title":"Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB","volume":"98","author":"Di","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier","volume":"288","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.117678_bib71","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11095-006-9905-5","article-title":"Brain uptake of nonsteroidal anti-inflammatory drugs: Ibuprofen, flurbiprofen, and indomethacin","volume":"23","author":"Parepally","year":"2006","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117678_bib72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01480545.2018.1432641","article-title":"Cytotoxicity of acetylcholinesterase reactivators evaluated in vitro and its relation to their structure","volume":"42","author":"Muckova","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117678_bib73","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/dmd.121.000458","article-title":"Metabolic activation and hepatotoxicity of Furan-containing compounds","volume":"50","author":"Tian","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2025.117678_bib74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/acph-2019-0024","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"S\u0142oczy\u0144ska","year":"2019","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2025.117678_bib75","first-page":"453","article-title":"Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development","volume":"58","author":"Baranczewski","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2025.117678_bib76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ddtec.2004.10.008","article-title":"Metabolic screening in vitro: metabolic stability, CYP inhibition and induction","volume":"1","author":"Riley","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2025.117678_bib77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2025.117678_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116364","article-title":"The role of the methoxy group in approved drugs","volume":"273","author":"Chiodi","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib79","first-page":"1987","article-title":"Comparison of commonly used and new methods to determine small molecule non-specific binding to human liver microsomes","volume":"113","author":"Wang","year":"2024","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/tx3003824","article-title":"Reactive metabolites in the biotransformation of molecules containing a Furan ring","volume":"26","author":"Peterson","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117678_bib81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/tx015574b","article-title":"Biotransformation reactions of five-membered aromatic heterocyclic rings","volume":"15","author":"Dalvie","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117678_bib82","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1021\/jm300343m","article-title":"Mitigating heterocycle metabolism in drug discovery","volume":"55","author":"St Jean","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib83","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/jm4007998","article-title":"Using deuterium in drug discovery: leaving the label in the drug","volume":"57","author":"Gant","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117678_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2018.08.010","article-title":"7-Methoxyderivative of tacrine is a \u201cfoot-in-the-door\u201d open-channel blocker of GluN1\/GluN2 and GluN1\/GluN3 NMDA receptors with neuroprotective activity in vivo","volume":"140","author":"Kaniakova","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.117678_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114953","article-title":"Mitochondrial damage precedes the changes of glutathione metabolism in CdCl2 treated neuronal SH-SY5Y cells","volume":"193","author":"Nyvltova","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117678_bib87","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.3390\/ijms24119124","article-title":"Structure-guided design of N-Methylpropargylamino-Quinazoline derivatives as multipotent agents for the treatment of alzheimer's disease","volume":"24","author":"Svobodova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115912","article-title":"Human coculture model of astrocytes and SH-SY5Y cells to test the neurotoxicity of chemicals","volume":"269","author":"Park","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ejmech.2025.117678_bib89","first-page":"151","article-title":"Biomimetic properties and estimated in vivo distribution of chloroquine and hydroxy-chloroquine enantiomers","volume":"9","author":"Valko","year":"2021","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejmech.2025.117678_bib90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpba.2016.04.009","article-title":"Lipophilicity and biomimetic properties measured by HPLC to support drug discovery","volume":"130","author":"Valk\u00f3","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2025.117678_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107183","article-title":"Use of biomimetic chromatography and in vitro assay to develop predictive GA-MLR model for use in drug-property prediction among anti-depressant drug candidates","volume":"175","author":"Ulenberg","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.ejmech.2025.117678_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462666","article-title":"Prediction of the chromatographic hydrophobicity index with immobilized artificial membrane chromatography using simple molecular descriptors and artificial neural networks","volume":"1660","author":"Ciura","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejmech.2025.117678_bib93","first-page":"191","article-title":"Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements","volume":"9","author":"Stergiopoulos","year":"2021","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejmech.2025.117678_bib94","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5599\/admet.530","article-title":"The role and impact of high throughput biomimetic measurements in drug discovery","volume":"6","author":"Bunally","year":"2018","journal-title":"ADMET and DMPK"},{"key":"10.1016\/j.ejmech.2025.117678_bib95","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.drudis.2016.07.007","article-title":"Quality guidelines for oral drug candidates: dose, solubility and lipophilicity","volume":"21","author":"Bayliss","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117678_bib96","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117678_bib97","doi-asserted-by":"crossref","first-page":"16882","DOI":"10.3390\/ijms140816882","article-title":"Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study","volume":"14","author":"Sepsova","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117678_bib98","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.talanta.2009.12.052","article-title":"Colorimetric dipstick for assay of organophosphate pesticides and nerve agents represented by paraoxon, sarin and VX","volume":"81","author":"Pohanka","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2025.117678_bib99","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00204-024-03689-3","article-title":"A-series agent A-234: initial in vitro and in vivo characterization","volume":"98","author":"Hrabinova","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117678_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115611","article-title":"2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1","volume":"258","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117678_bib101","unstructured":"Microsomal stability | cyprotex ADME-tox solutions, evotec website (English) (n.d.). https:\/\/www.evotec.com\/en\/drug-metabolism\/microsomal-stability (accessed February 12, 2025)."},{"key":"10.1016\/j.ejmech.2025.117678_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108528","article-title":"Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors","volume":"189","author":"Kolcheva","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.117678_bib103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vascn.2017.06.001","article-title":"Comparison of glutathione levels measured using optimized monochlorobimane assay with those from ortho-phthalaldehyde assay in intact cells","volume":"88","author":"\u010capek","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejmech.2025.117678_bib104","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1567205015666171212105412","article-title":"Cholinesterase inhibitor 6-Chlorotacrine - in vivo toxicological profile and behavioural effects","volume":"15","author":"Misik","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2025.117678_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117201","article-title":"Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition","volume":"178","author":"Misiachna","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117678_bib106","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/09553002.2012.654044","article-title":"Activation of p38 MAPK and expression of TGF-\u03b21 in rat colon enterocytes after whole body \u03b3-irradiation","volume":"88","author":"Pejchal","year":"2012","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ejmech.2025.117678_bib107","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/acschemneuro.1c00184","article-title":"Phenothiazine-tacrine heterodimers: pursuing multitarget directed approach in alzheimer's disease","volume":"12","author":"Gorecki","year":"2021","journal-title":"ACS Chem. Neurosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500443X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500443X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:21Z","timestamp":1777529301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500443X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":106,"alternative-id":["S022352342500443X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117678","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel tacrine-based multi-target directed Ligands: Enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117678"}}